Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China · Delayed Price · Currency is CNY 9.31
+0.11 (1.20%)
Sep 14, 2026, 3:04 PM CST
Yifan Pharmaceutical Revenue
Yifan Pharmaceutical had revenue of 1.21B CNY in the quarter ending June 30, 2026, a decrease of -7.37%. This brings the company's revenue in the last twelve months to 4.97B, down -3.82% year-over-year. In the year 2025, Yifan Pharmaceutical had annual revenue of 5.13B, down -0.52%.
Revenue (ttm)
4.97B
Revenue Growth
-3.82%
P/S Ratio
1.94
Revenue / Employee
1.19M
Employees
4,182
Market Cap
9.65B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.13B | -26.87M | -0.52% |
| Dec 31, 2024 | 5.16B | 1.09B | 26.84% |
| Dec 31, 2023 | 4.07B | 231.47M | 6.03% |
| Jan 1, 2023 | 3.84B | -572.39M | -12.98% |
| Jan 1, 2022 | 4.41B | -991.34M | -18.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.82B |
| Zhejiang Int'l Group | 34.20B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.21B |
| GuangYuYuan Chinese Herbal Medicine | 1.41B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.09B |
| Shanghai InnoStar Bio-tech | 901.08M |
| Chongqing Lummy Pharmaceutical | 748.94M |
| Hangzhou Bio-Sincerity Pharma-Tech | 709.72M |